Precise Infliximab Exposure and Pharmacodynamic Control
Clinical trial NCT05660746 · RECRUITING
Trial details
- NCT number
- NCT05660746
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2027-03-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.